Latest recommendation updates
- has been published
- has been updated for additional booster dose administration errors.
Recent ATAGI considerations
On Wednesday 20 April 2022, ATAGI met to consider the latest developments relating to COVID-19 immunisation. As of 19 April 2022, of COVID-19 vaccines have been administered in Australia.
Use of Booster doses in adolescents aged 12-15 years
On 8 April 2022 TGA provisionally approved the Pfizer COVID-19 vaccine as a booster in people aged 12-15 years. ATAGI released that it does not recommend booster doses of Pfizer COVID-19 vaccine in this age group, at this time.
ATAGI is continuing to consider evidence on the benefits and risks of boosters in this age group including the epidemiology, adverse events, and evidence of groups at higher risk of severe disease or groups that will benefit from further doses. ATAGI will update recommendations if required.
ATAGI continues to recommend young people aged 5 to 15 years receive a primary course of a COVID-19 vaccine, including those who may have previously had COVID-19. For most people this is 2 doses, or 3 primary doses for people who are severely immunocompromised.
